GB2268871A - Composition for use as a food or food supplement - Google Patents
Composition for use as a food or food supplement Download PDFInfo
- Publication number
- GB2268871A GB2268871A GB9313858A GB9313858A GB2268871A GB 2268871 A GB2268871 A GB 2268871A GB 9313858 A GB9313858 A GB 9313858A GB 9313858 A GB9313858 A GB 9313858A GB 2268871 A GB2268871 A GB 2268871A
- Authority
- GB
- United Kingdom
- Prior art keywords
- vitamin
- mcg
- composition according
- composition
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 98
- 235000013305 food Nutrition 0.000 title claims abstract description 16
- 235000015872 dietary supplement Nutrition 0.000 title claims abstract description 12
- 229940088594 vitamin Drugs 0.000 claims abstract description 23
- 229930003231 vitamin Natural products 0.000 claims abstract description 23
- 235000013343 vitamin Nutrition 0.000 claims abstract description 23
- 239000011782 vitamin Substances 0.000 claims abstract description 23
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 15
- 235000010755 mineral Nutrition 0.000 claims abstract description 15
- 239000000126 substance Substances 0.000 claims abstract description 10
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 10
- 235000015097 nutrients Nutrition 0.000 claims abstract description 8
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 8
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 8
- 235000020774 essential nutrients Nutrition 0.000 claims abstract description 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 6
- 239000011573 trace mineral Substances 0.000 claims abstract description 5
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 5
- 229920001184 polypeptide Polymers 0.000 claims abstract description 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 3
- 229940024606 amino acid Drugs 0.000 claims description 43
- 235000001014 amino acid Nutrition 0.000 claims description 43
- 150000001413 amino acids Chemical class 0.000 claims description 43
- 239000000284 extract Substances 0.000 claims description 32
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 28
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 26
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 24
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 22
- 229920002477 rna polymer Polymers 0.000 claims description 22
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 claims description 19
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 claims description 19
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 18
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 18
- 239000002775 capsule Substances 0.000 claims description 15
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 13
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 13
- 229930003268 Vitamin C Natural products 0.000 claims description 13
- 229930003427 Vitamin E Natural products 0.000 claims description 13
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 13
- 239000011669 selenium Substances 0.000 claims description 13
- 229910052711 selenium Inorganic materials 0.000 claims description 13
- 235000019154 vitamin C Nutrition 0.000 claims description 13
- 239000011718 vitamin C Substances 0.000 claims description 13
- 235000019165 vitamin E Nutrition 0.000 claims description 13
- 229940046009 vitamin E Drugs 0.000 claims description 13
- 239000011709 vitamin E Substances 0.000 claims description 13
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 12
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 12
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 12
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 12
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 12
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 12
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 12
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 12
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 12
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 12
- 229960000304 folic acid Drugs 0.000 claims description 12
- 235000019152 folic acid Nutrition 0.000 claims description 12
- 239000011724 folic acid Substances 0.000 claims description 12
- 229960000310 isoleucine Drugs 0.000 claims description 12
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 12
- 229930182817 methionine Natural products 0.000 claims description 12
- 239000004474 valine Substances 0.000 claims description 12
- 235000019155 vitamin A Nutrition 0.000 claims description 12
- 239000011719 vitamin A Substances 0.000 claims description 12
- 229940045997 vitamin a Drugs 0.000 claims description 12
- 239000004475 Arginine Substances 0.000 claims description 11
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 11
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 11
- 239000004471 Glycine Substances 0.000 claims description 11
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 11
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 11
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 11
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 11
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 11
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 11
- 239000004472 Lysine Substances 0.000 claims description 11
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 11
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 11
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 11
- 239000004473 Threonine Substances 0.000 claims description 11
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 11
- 235000004279 alanine Nutrition 0.000 claims description 11
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 11
- 235000009697 arginine Nutrition 0.000 claims description 11
- 235000003704 aspartic acid Nutrition 0.000 claims description 11
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 11
- 239000011575 calcium Substances 0.000 claims description 11
- 229910052791 calcium Inorganic materials 0.000 claims description 11
- 235000013922 glutamic acid Nutrition 0.000 claims description 11
- 239000004220 glutamic acid Substances 0.000 claims description 11
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 11
- 235000013930 proline Nutrition 0.000 claims description 11
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 11
- 235000004400 serine Nutrition 0.000 claims description 11
- 235000002374 tyrosine Nutrition 0.000 claims description 11
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 11
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 10
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 10
- 235000018417 cysteine Nutrition 0.000 claims description 10
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 10
- 239000003797 essential amino acid Substances 0.000 claims description 10
- 229960003495 thiamine Drugs 0.000 claims description 10
- 239000011701 zinc Substances 0.000 claims description 10
- 229910052725 zinc Inorganic materials 0.000 claims description 10
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 9
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 9
- 229930003779 Vitamin B12 Natural products 0.000 claims description 9
- 229960002685 biotin Drugs 0.000 claims description 9
- 235000020958 biotin Nutrition 0.000 claims description 9
- 239000011616 biotin Substances 0.000 claims description 9
- 210000004204 blood vessel Anatomy 0.000 claims description 9
- 235000020776 essential amino acid Nutrition 0.000 claims description 9
- 229910052742 iron Inorganic materials 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 9
- 210000001519 tissue Anatomy 0.000 claims description 9
- 235000019163 vitamin B12 Nutrition 0.000 claims description 9
- 239000011715 vitamin B12 Substances 0.000 claims description 9
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 8
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 8
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 8
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 8
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 8
- 229930003451 Vitamin B1 Natural products 0.000 claims description 8
- 229910052804 chromium Inorganic materials 0.000 claims description 8
- 239000011651 chromium Substances 0.000 claims description 8
- 239000011777 magnesium Substances 0.000 claims description 8
- 229910052749 magnesium Inorganic materials 0.000 claims description 8
- 229960003512 nicotinic acid Drugs 0.000 claims description 8
- 229960002477 riboflavin Drugs 0.000 claims description 8
- 239000003826 tablet Substances 0.000 claims description 8
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 8
- 235000010374 vitamin B1 Nutrition 0.000 claims description 8
- 239000011691 vitamin B1 Substances 0.000 claims description 8
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims description 7
- 229930003471 Vitamin B2 Natural products 0.000 claims description 7
- 229910052796 boron Inorganic materials 0.000 claims description 7
- 210000003205 muscle Anatomy 0.000 claims description 7
- 235000018102 proteins Nutrition 0.000 claims description 7
- 210000003491 skin Anatomy 0.000 claims description 7
- 235000019164 vitamin B2 Nutrition 0.000 claims description 7
- 239000011716 vitamin B2 Substances 0.000 claims description 7
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 7
- 235000005282 vitamin D3 Nutrition 0.000 claims description 6
- 239000011647 vitamin D3 Substances 0.000 claims description 6
- 229940011671 vitamin b6 Drugs 0.000 claims description 6
- 229940021056 vitamin d3 Drugs 0.000 claims description 6
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 5
- 244000194101 Ginkgo biloba Species 0.000 claims description 5
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 5
- 229930003316 Vitamin D Natural products 0.000 claims description 5
- 229960000367 inositol Drugs 0.000 claims description 5
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 5
- 239000011630 iodine Substances 0.000 claims description 5
- 229910052740 iodine Inorganic materials 0.000 claims description 5
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 5
- 235000019166 vitamin D Nutrition 0.000 claims description 5
- 239000011710 vitamin D Substances 0.000 claims description 5
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 5
- 229940046008 vitamin d Drugs 0.000 claims description 5
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims description 4
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 4
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 4
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 150000007513 acids Chemical class 0.000 claims description 4
- 210000004907 gland Anatomy 0.000 claims description 4
- 235000008216 herbs Nutrition 0.000 claims description 4
- 239000007937 lozenge Substances 0.000 claims description 4
- 229910052748 manganese Inorganic materials 0.000 claims description 4
- 239000011572 manganese Substances 0.000 claims description 4
- 229910052750 molybdenum Inorganic materials 0.000 claims description 4
- 239000011733 molybdenum Substances 0.000 claims description 4
- 229940055726 pantothenic acid Drugs 0.000 claims description 4
- 235000019161 pantothenic acid Nutrition 0.000 claims description 4
- 239000011713 pantothenic acid Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 4
- 235000019158 vitamin B6 Nutrition 0.000 claims description 4
- 239000011726 vitamin B6 Substances 0.000 claims description 4
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 3
- 241001061264 Astragalus Species 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 240000003444 Paullinia cupana Species 0.000 claims description 3
- 235000000556 Paullinia cupana Nutrition 0.000 claims description 3
- 240000000143 Turnera diffusa Species 0.000 claims description 3
- 235000006533 astragalus Nutrition 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- 235000013399 edible fruits Nutrition 0.000 claims description 3
- 239000000787 lecithin Substances 0.000 claims description 3
- 229940067606 lecithin Drugs 0.000 claims description 3
- 235000010445 lecithin Nutrition 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000002366 mineral element Substances 0.000 claims description 3
- 235000001968 nicotinic acid Nutrition 0.000 claims description 3
- 239000011664 nicotinic acid Substances 0.000 claims description 3
- 210000000056 organ Anatomy 0.000 claims description 3
- 210000004233 talus Anatomy 0.000 claims description 3
- 235000004952 turnera diffusa Nutrition 0.000 claims description 3
- 241000283690 Bos taurus Species 0.000 claims description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 2
- 229960001231 choline Drugs 0.000 claims description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 2
- 235000008524 evening primrose extract Nutrition 0.000 claims description 2
- 229940089020 evening primrose oil Drugs 0.000 claims description 2
- 239000010475 evening primrose oil Substances 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 239000011737 fluorine Substances 0.000 claims description 2
- 229910052731 fluorine Inorganic materials 0.000 claims description 2
- 229940107131 ginseng root Drugs 0.000 claims description 2
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 claims description 2
- 231100000252 nontoxic Toxicity 0.000 claims description 2
- 230000003000 nontoxic effect Effects 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 1
- -1 Valerian Chemical compound 0.000 claims 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 1
- 239000004554 water soluble tablet Substances 0.000 claims 1
- 239000011707 mineral Substances 0.000 abstract description 13
- 239000004615 ingredient Substances 0.000 description 25
- 239000013522 chelant Substances 0.000 description 24
- 238000009472 formulation Methods 0.000 description 17
- 210000000987 immune system Anatomy 0.000 description 15
- 238000005538 encapsulation Methods 0.000 description 12
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 230000036541 health Effects 0.000 description 11
- 229960002885 histidine Drugs 0.000 description 10
- 229960004441 tyrosine Drugs 0.000 description 10
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 9
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 8
- 229960002079 calcium pantothenate Drugs 0.000 description 8
- 210000000653 nervous system Anatomy 0.000 description 8
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 7
- 230000035882 stress Effects 0.000 description 7
- 230000009286 beneficial effect Effects 0.000 description 6
- 210000000988 bone and bone Anatomy 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 6
- 210000002307 prostate Anatomy 0.000 description 6
- 235000019156 vitamin B Nutrition 0.000 description 6
- 239000011720 vitamin B Substances 0.000 description 6
- 235000019160 vitamin B3 Nutrition 0.000 description 6
- 239000011708 vitamin B3 Substances 0.000 description 6
- 229930003537 Vitamin B3 Natural products 0.000 description 5
- 229930003571 Vitamin B5 Natural products 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 210000001685 thyroid gland Anatomy 0.000 description 5
- 235000009492 vitamin B5 Nutrition 0.000 description 5
- 239000011675 vitamin B5 Substances 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 4
- 206010003246 arthritis Diseases 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 210000002808 connective tissue Anatomy 0.000 description 4
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 230000009245 menopause Effects 0.000 description 4
- 230000001568 sexual effect Effects 0.000 description 4
- 229940033282 vitamin b6 2 mg Drugs 0.000 description 4
- 239000005913 Maltodextrin Substances 0.000 description 3
- 229920002774 Maltodextrin Polymers 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 235000009499 Vanilla fragrans Nutrition 0.000 description 3
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 3
- 210000004100 adrenal gland Anatomy 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 230000001079 digestive effect Effects 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 210000004209 hair Anatomy 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 229940035034 maltodextrin Drugs 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 208000010392 Bone Fractures Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000195480 Fucus Species 0.000 description 2
- 206010062767 Hypophysitis Diseases 0.000 description 2
- 240000003394 Malpighia glabra Species 0.000 description 2
- 235000014837 Malpighia glabra Nutrition 0.000 description 2
- 208000019914 Mental Fatigue Diseases 0.000 description 2
- 206010029216 Nervousness Diseases 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 240000009164 Petroselinum crispum Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 201000001880 Sexual dysfunction Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- 244000126014 Valeriana officinalis Species 0.000 description 2
- 235000013832 Valeriana officinalis Nutrition 0.000 description 2
- 244000263375 Vanilla tahitensis Species 0.000 description 2
- 239000003048 aphrodisiac agent Substances 0.000 description 2
- 230000002509 aphrodisiac effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000133 brain stem Anatomy 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000000639 cyanocobalamin Nutrition 0.000 description 2
- 239000011666 cyanocobalamin Substances 0.000 description 2
- 229960002104 cyanocobalamin Drugs 0.000 description 2
- 229940068063 damiana extract Drugs 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 235000011197 perejil Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 210000003635 pituitary gland Anatomy 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000008160 pyridoxine Nutrition 0.000 description 2
- 239000011677 pyridoxine Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 235000019157 thiamine Nutrition 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- 210000000515 tooth Anatomy 0.000 description 2
- 235000016788 valerian Nutrition 0.000 description 2
- 230000036642 wellbeing Effects 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- UPLPHRJJTCUQAY-WIRWPRASSA-N 2,3-thioepoxy madol Chemical compound C([C@@H]1CC2)[C@@H]3S[C@@H]3C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@](C)(O)[C@@]2(C)CC1 UPLPHRJJTCUQAY-WIRWPRASSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- 235000000509 Chenopodium ambrosioides Nutrition 0.000 description 1
- 244000098897 Chenopodium botrys Species 0.000 description 1
- 235000005490 Chenopodium botrys Nutrition 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010305 Confusional state Diseases 0.000 description 1
- 239000004150 EU approved colour Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000195950 Equisetum arvense Species 0.000 description 1
- 239000005768 Equisetum arvense L. Substances 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 108010058643 Fungal Proteins Proteins 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000006670 Multiple fractures Diseases 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 244000134552 Plantago ovata Species 0.000 description 1
- 235000003421 Plantago ovata Nutrition 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 239000009223 Psyllium Substances 0.000 description 1
- 241000282806 Rhinoceros Species 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 244000290333 Vanilla fragrans Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 208000007642 Vitamin B Deficiency Diseases 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 235000021015 bananas Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 230000003913 calcium metabolism Effects 0.000 description 1
- 229940086392 calcium pantothenate 7 mg Drugs 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000001638 cerebellum Anatomy 0.000 description 1
- 235000019993 champagne Nutrition 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960004874 choline bitartrate Drugs 0.000 description 1
- QWJSAWXRUVVRLH-UHFFFAOYSA-M choline bitartrate Chemical compound C[N+](C)(C)CCO.OC(=O)C(O)C(O)C([O-])=O QWJSAWXRUVVRLH-UHFFFAOYSA-M 0.000 description 1
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 210000002451 diencephalon Anatomy 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000005225 erectile tissue Anatomy 0.000 description 1
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 210000004905 finger nail Anatomy 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000019264 food flavour enhancer Nutrition 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 230000000796 hypoacidity effect Effects 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940087400 lecithin 50 mg Drugs 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 231100000863 loss of memory Toxicity 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 229940051960 magnesium oxide 50 mg Drugs 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-OUBTZVSYSA-N magnesium-25 atom Chemical compound [25Mg] FYYHWMGAXLPEAU-OUBTZVSYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000004220 muscle function Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000006014 omega-3 oil Substances 0.000 description 1
- 229940006093 opthalmologic coloring agent diagnostic Drugs 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 208000001685 postmenopausal osteoporosis Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229940070687 psyllium Drugs 0.000 description 1
- 235000021013 raspberries Nutrition 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 229940071440 soy protein isolate Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229940051923 vitamin E 15 mg Drugs 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention provides a formulated composition for use as a food or food supplement. The composition comprises a proteinaceous component selected from at least one protein, peptide, polypeptide, or a mixture thereof. The composition also includes an essential nutrient component which is at least one nutrient substance selected from a vitamin, mineral, trace element or mixture thereof. The proteinaceous component is present in an amount of from about 1x10<-8> g to about 10 g per recommended daily allowance of at least one nutrient substance in the essential nutrient component.
Description
COMPOSITION FOR USE AS A FOOD OR FOOD SUPPLEMENT
The present invention relates to a composition for use as a food or food supplement, in particular a food supplement to enhance the lifestyle of men and women.
Since the beginning of recorded time there have been foods which were thought to be beneficial in various aspects of life. For example, certain foods were thought to increase the sexual potency of those who ate them. Even the ancient
Gods had their own food called Ambrosia.
Nowadays, oysters and caviar are two of the most popular of such foods. Herbs from the Middle East are others.
Rhinoceros horn yet another, as well as extracts of bulls testicles, the blood of young virile lions, to mention but a few. There are also certain vitamins such as Vitamin E with its effect on the circulation. Furthermore, the root of ginseng has become very popular and has gained quite a reputation amongst health food users. Champagne, it has to be good, should also appear on a list of aphrodisiacs as should certain fruits such as apricots, bananas, oranges and raspberries.
You are what you make of what you eat. After all his years of practice the inventor has to say that without doubt he subscribes to this theory. As a priority he began research into a new product which would be a modern food supplement for use i enhancing the lifestyle of men and women, for example, those suffering especially from the stress and strain of modern life.
According to the inventor's surprising discovery, a food or food supplement, especially one with particular qualities for men and women, can be formulated by combining a proteinaceous component and an essential nutrient component in particular amounts per se and in particular proportions.
Thus, in one aspect, the present invention provides a formulated composition for use as a food or food supplement, which composition comprises a proteinaceous component comprising at least one protein, peptide, polypeptide, or amino acid and an essential nutrient component comprising at least one nutrient substance which is a vitamin, mineral or trace element, the proteinaceous component being present in an amount of from about lox10 8 g to about 10 g per recommended daily allowance of at least one nutrient substance in the essential nutrient component.
Preferably, the composition of the invention is in discrete portion form. Typically, such may be in the form of a tablet, pill, lozenge or capsule. More preferably, the composition is in the form of a chewable, suckable, watersoluble or slow-release tablet or lozenge.
Alternatively, the composition of the invention may be in the form of a gum, a powder or a solution or suspension in a non-toxic liquid.
Thus, the composition may include one or more liquid or solid carriers, diluents or excipients. Alternatively or additionally, and more preferably, the composition may be contained within the shell of a capsule.
Typical such carriers etc. are well known. However, as a preferred example the composition of the invention may be formulated in solid form using a carrier etc. comprising maltodextrin.
In the composition of the invention the proteinaceous material preferably comprises at least one tissular extract of glands, organs, blood vessels, muscle, skin etc.
More preferably, the proteinaceous material comprises at least one tissular extract obtained by purification e.g. by filtration etc., of non-human animal tissue, both foetal and adult, of all types, but excluding bovine tissue.
The tissular extract for use in the composition of the invention may be prepared in any convenient manner which provides an extract suitable for human consumption.
Preferably, however, the extract is prepared by mixing homogenised tissue material from sheep with homogenised tissue material from pigs. The mixture is then filtered and purified to a degree making it fit for human consumption, after which it may be incorporated in a composition as defined herein. Alternatively, tissue material of one species may be introduced into another spaies to result in the preparation of a specific protein within the host e.g. animal or yeast.
Alternatively, or additionally, the proteinaceous material used in the composition of the invention may be ribonucleic acid (RNA) and/or adenosine triphosphate (ATP). Preferably the RNA is a naturally occurring RNA such as RNA in yeast or plant proteins and preferably the ATP is that obtained as a cell extract. Typically, the RNA may be used in an amount of from about 10 to about 50 mg, preferably about 25 mg, per RDA. Similarly, the ATP may be used in an amount of from about 1 to about 10 mg, preferably about 2 mg, per RDA.
The principle of preferred compositions according to the invention which enhance lifestyle or well-being is that they comprise a food or food supplement. They are not a drug having a medicinal effect and were never formulated to be a drug.
Thus, for example, compositions in accordance with the invention may be formulated with the following lifestyle aspects in mind, namely:
Sexual potency
Skin tone and health
Youthful vigour and vitality
Control of prostate problems
Control of menopause problems
Control of rheumatism and arthritis
Control of immune system problems
Control of stress
Improvement of mental function
Enhancement of heart function and circulation.
In preferred compositions I have put together a mixture of vitamins which are regarded as having some effect on say one's love life. At least they have been publicised as such and during my exhaustive consultations with many of my patients over nearly 30 years, I have found that those who were taking certain of the vitamins and other ingredients contained in the compositions of the invention all claimed that they felt better. Many said that it did seem to have a beneficial effect on lifestyle and well-being with concomitant beneficial effects on, for example, their love life. After all, to have a full and happy love life you have to feel good and energetic and that is what the compositions of this invention are designed to do by supplementing the body's nutrition.
Amongst preferred constituents are:
Specially prepared nutritional proteins of the individual tissues, for example, those known to be related to sexual problems. These include the glands, circulatory system and nervous system and are known to add to the potency of this health food supplement.
Vitamins; it is recommended that we all take additional vitamins. It seems that in spite of improvements in farming the food we eat does not generally contain as much of the vitamins that we need. This is very interesting since vitamins are a very important part of nutrition, described in the dictionary as "any of a group of substances that are essential, in small quantities, for the normal functioning of metabolism in the body". They cannot usually be synthesised in the body but they occur naturally in certain foods.
There are a great number of different vitamins. Each has a different property and important part to play in general health. Vitamin A is vital to the health of the eyes, skin, bone, teeth and immune system. Currently, vitamin A is regarded as a valuable agent in preventing some of the degenerative diseases associated with ageing. It is regarded as assisting with the protection of the epithelial tissue (cellular tissue covering the whole of the body) against malignant changes (i.e. cancer). It also prevents the decline in the function of the immune system.
Vitamin B complex is a large group of some eleven different vitamins. These vitamins are water soluble which means they have to be replenished daily since the body does not store them. Stress for example speeds up our rate of use of the vital B vitamins, so the more stress we are subjected to in our daily lives the more it is necessary to replenish the supplies. The B vitamins help with the production of energy within the body. The symptoms of vitamin B deficiency include mental fatigue and confusion as well as loss of memory. Specifically, the B vitamins are made up of:
Thiamine - vitamin B - important in energy production
as well as the condition of the skin and
finger nails.
Niacin - vitamins B3 - essential for the body's total
metabolism, deficiencies can lead to poor
skin, digestive and nervous problems.
Pyridoxine - vitamin B6 - important in the metabolism of
fat, proteins and carbohydrates. Influences
energy levels particularly to the heart,
brain and liver. Sometimes this vitamin is
used to help people with menstrual tension,
cramps and depression.
Folic Acid - important for the healthy function of the
nervous system, hair, immune system, mucous
membranes and liver.
Cobalamin - vital for the health of the red blood cells
and nervous system. More is required as we
get older because the body does not utilise
it so easily.
Pantothenic Acid
- helps to fight against the effects of
stress. It strengthens the adrenal glands
and immune system. It is also been used to
help people with arthritic diseases.
Biotin - important for the health of the digestive
tract, the skin, hair, adrenal glands,
thyroid gland, as well as the reproductive
system.
Choline - improves the brain and nervous system
especially in older people.
Inositol - helps with the brain and nervous system.
Para-aminobenzoic Acid
- thought to affect the hair including the
colour.
Vitamin C - this vitamin is a major antioxidant. It
prevents the formation of free radicals
(biological substances which cause havoc to
the body). It is vital to the health of the
skin, bones, teeth, blood vessels, tendons
and cartilage. The immune system depends
upon supplies of vitamin C as does the vital
connective tissues. Without this vitamin
the body is more likely to suffer
infections, poor skin, fatigue, bleeding
problems, heart disease, and possibly some
forms of cancer.
Vitamin D - often called the sunshine vitamin because
the skin manufactures this vitamin when
exposed to the sun. It helps with the
calcium metabolism and so effects the health
of the bones.
Vitamin E - along with vitamin C this is regarded as the
vitamin of youth. Respected as having an
influence on sexual function and fertility.
It also acts as a strong antioxidant
fighting free radicals in the system.
Preferred levels of vitamins per daily amount of composition may be as follows:
Vitamin A - about 0.5 to about 1.0 mg
Vitamin B1 - about 0.5 to about 1.5 mg
Vitamin B2 - about 0.5 to about 1.7 mg
Niacin - about 15.0 to about 19.0 mg
Vitamin B6 - about 1.0 to about 2.2. mg
Pantothenic Acid - about 5.0 to about 7.0 mg
Biotin - about 150.0 to about 200.0 mcg
Folic Acid - about 300.0 to about 400.0 mcg
Vitamin B12 - about 2.0 to about 3.0 mcg
Vitamin C - about 30.0 to about 60.0 mg
Vitamin D3 - about 2.5 to about 10.0 mcg
Vitamin E - about 5.0 to about 20.0 mg
As well as a daily intake of all the necessary vitamins the human body also needs important minerals. These are:
Calcium - as well as being vital for the health and
development of the bones of the body,
calcium also affects the nerves and muscles.
Very necessary for women during the
menopause to avoid bone problems. Older
people generally are prone to developing
brittle bones which in turn are prone to
easy breakage or fracture.
Chromium - a vital mineral for the utilisation of blood
sugars to produce energy. This mineral
works closely with the body's natural
insulin.
Iodine - this mineral works on the thyroid gland
helping to keep it in balance so improving
the overall health of the body and correct
metabolism of fats as well as temperature
regulation.
Iron - this mineral is important to the structure
and function of the haemoglobin, which is a
vital part of the red blood cells that carry
oxygen around the body. Without iron the
blood will not carry oxygen and the result
is anaemia and fatigue. Older people are
more prone to this condition and it is
thought by many to have a direct influence
on impotence and sexual problems.
Magnesium - most cell functions are controlled by this
mineral. When this vital mineral is missing
or not available in sufficient quantities
premature ageing and illness occur.
Potassium - the muscles of the body depend upon this
mineral for their general health and
strength.
Selenium - this mineral is a powerful antioxidant and
helps to detoxify the system. It is thought
to help against cancer and heart disease as
well as helping the body fight external
pollution.
Zinc - this mineral is important to the health of
the prostate, sex glands and organs, the
immune system and to the metabolism
generally.
Boron - this mineral is beneficial in the prevention
of osteoporosis.
Up to the present time, the authorities of various countries, as well as International bodies, have attempted to define in various ways the minimum daily human requirements of the above-listed trace elements and mineral elements. Thus, in some countries such as the UK, there is a recommended daily dietary allowance (RDA) figure for certain of the listed elements, whereas for other elements no such UK RDA figure has so far been given. Furthermore, the RDA figure for any particular element can vary from country to country.
Nevertheless, the National Academy of Sciences in the USA has sought to define a range of Adequate Daily Dietary
Intake (ADDI) for each necessary element, and the figures given below are taken from "Recommended Dietary Allowances"
Ninth Revised Edition, 1980, National Academy of Sciences
Washington, DC. However, it is to be understood that where for any particular country an RDA figure is lower or higher, that figure may be adopted as necessary or desired within the limitations of the invention as defined herein.
In the UK the only RDA figures given for the above-listed elements are as follows:
Calcium - about 500 mg
Iron - about 12 mg
Iodine - about 140 mcg.
and the remaining elements are not assigned an "official"
RDA. Notwithstanding that lack of information in the UK preferred minimum levels taken from the US ADDI ranges can be stated as follows:
Calcium - about 800 mg
Phosphorous - about 800 mg
Magnesium - about 300 mg, for example, about 300 to
about 400 mg, typically about 350 mg
Iron - about 18 mg
Iodine - about 150 mcg
Fluorine - about 1.5 mg, for example, about 1.5 to
about 4.0 mg
Zinc - about 15.0 mg
Copper - from about 2.0 to about 3.0 mg
Manganese - from about 2.5 to about 5.0 mg, typically
about 4 mg
Selenium - about 50 mcg, for example, about 50 to about
200 mcg, typically about 60 mcg
Chromium - about 50 mcg, for example, about 50 to about
200 mcg, typically about 60 mcg
Boron - about 1 to about 5 mg, preferably about 2 mg
Molybdenum - about 150 mcg, for example, about 150 to
about 500 mcg.
In Denmark and other Scandinavian countries there is a more recent tendency to set the figures for selenium, chromium and molybdenum higher than the minimum figures given above although within the above ranges. For example, in Denmark it is currently recommended that the typical daily amount of selenium should be about 125 mcg and that the corresponding figures for chromium and molybdenum should be about 125 mcg and about 250 mcg respectively.
In a food supplement for people who want to improve their skin chromium, the amino acids and Aquisetum Arnense, which is a natural astringent and also a diuretic which helps the skin to rid itself of toxins and remain youthful, are useful. In addition, the Fruit Acids can help reduce wrinkles and fine lines.
In the control of the menopause, boron which is a trace mineral found in plants is beneficial in the prevention of post-menopausal osteoporosis. It is also beneficial in the treatment of arthritis and builds muscle.
In the control of immune system problems, Kelp can help with the thyroid function and Astragalus, which is an ancient chinese herb can help with the immune system and also with the fight against cancer. In addition, Bee
Pollen is useful.
In the control of stress, the herb myo-inositol can help strengthen the nervous system and lecithin can help the nervous system.
In the improvement of mental function Ginkgo Biloba which is an ancient Chinese herb may be useful, as well as Kelp and Bee Pollen. Ginkgo Biloba which comes from the world's oldest trees may also be useful in rejuvenation or youth products and as a general elixir. It also helps with lung complaints. Bee Pollen which helps regenerate the body generally also helps with problems involving the prostate, with arthritis and with heart problems.
In the enhancement of sexual potency, Guarana and Damiana, two natural herbs occurring in Mexico and Brazil are useful. Daminana has aphrodisiac properties and Guarana has stimulatory properties.
Within other contexts:
Valerian can help with insomnia and hysteria. It also
helps with menstrual problems, general anxiety and
nervousness.
L-Carnitine can help protect the body against
cardiovascular disease and against muscular
degeneration.
Other important nutritional substances include enzymes which are special proteins each of which accelerates the rate of a specific chemical reaction without taking part in it. Without enzymes life could not exist. They often work together with vitamins and/or minerals.
Amino acids comprise essential and non-essential amino acids. Essential amino acids cannot be made by the body and have to be taken from the food we eat. Non-essential amino acids can be made by the body from existing essential amino acids.
The essential amino acids are:
isoleucine - which is essential for the formulation of
haemoglobin
phenylalanine - which enhances learning and memory
leucine - which helps with the healing of broken bones
threonine - which helps with liver function and in
building up the immune system.
lysine - which inhibits the growth of viruses and aids
the adsorption of calcium.
tryptophan - which has been proposed for the treatment
of senile dementia
methionine - which helps to prevent hair loss and is
an anti-fatigue agent, and
valine - which is used in the treatment of severe
amino acid deficiencies.
The non-essential amino acids include:
alanine - which is used by the body to fuel the
nervous system and brain. It also builds up the
immune system
glycine - which also helps to build up the immune
system and helps with the management of hypo-acidity
arginine - which stimulates the release of growth
hormone. It also helps healing and to combat physical
and mental fatigue. In addition, it is used in the
treatment of liver disorders
proline - which is important for the proper function
of the joints and tendons, it also helps the heart
muscle and is a major constituent of collagen
aspartic acid - which increases resistance to fatigue.
It also helps with the formation of RNA and builds up
the immune system
serine - which helps with liver and muscle function.
It also builds up the immune system
cysteine - which helps with hair growth. It also
helps protect the brain and liver from alcohol and
other damage. It helps to detoxify the body
tyrosine - which plays an important part in helping
the function of the pituitary gland, as well as
adrenal and thyroid gland function. It also helps to
generate the production of red and white cells
glutamic acid - which is important for brain
metabolism. It helps the brain to function, it
increases blood sugar levels and helps with the
management of hypo-glycaemia.
One or more of all of these vital constituents are preferably to be found in the composition of the invention.
Furthermore, the composition preferably may include extracts of herbs known to have properties relating say to sexual potency including the herb Damiana found in Mexico, as well as extract of evening primrose oil and ginseng root regarded for a long time as having aphrodisiacal properties.
In addition, the composition of the invention may include other ingredients which make it more acceptable for consumption. For example, it may include one or more colouring agents for visual effect, one or more flavouring agents such as vanilla for organoleptic effect, as well as flavour enhancers. Also, ingredients with "health food" overtones may be included such as wheat germ.
The compositions of the invention will now be described in more detail with reference to the following specific
Examples.
Example 1
A composition in accordance with the invention was prepared according to the following formulation:
Ingredient Amount er suckable Tablet %RDA
Maltodextrin 1154 mg
Wheat Germ 250 mg
Amino Acid Complex* 200 mg
Ginseng Extract 461 125 mg
Silica Dioxide 125 mg
Acerola Powder 100 mg
Damiana Extract 4.1 75 mg
Vitamin C 33 mg 100
Magnesium Stearate 25 mg
Vitamin E 15 mg
Vanilla 10 mg
Magnesium Oxide 10 mg
Zinc Gluconate 58 mg
Manganese Sulphate 6.25 mg
Calcium Pantothenate 7 mg
Vitamin A Acetate 750 mcg 100
Folic Acid 300 mcg 100
Tissular Proteins 10 mcg
Vitamin D 2.5 mcg 100
Vitamin B12 2 mcg 100
Total: 2194.4 mg *Amino Acid Complex Amount per suckable Tablet
Glycine 41.80 mg
Proline 27.58 mg
Hydroxyproline 24.34 mg
Glutamic Acid 20.00 mg
Alanine 17.56 mg
Arginine 15.78 mg
Aspartic Acid 11.58 mg
Lysine 7.88 mg
Serine 6.96 mg
Leucine 5.74 mg
Valine 4.38 mg
Phenylalanine 3.98 mg
Threonine 3.76 mg
Isoleucine 2.96 mg
Hydroxylysine 1.72 mg
Methionine 1.56 mg
Histidine 1.38 mg
Tyrosine 0.52 mg
Total: 199.48 mg
The above formulation was prepared in discrete form as 2 gram (nominal size) suckable tablets with a pleasant vanilla taste and of extremely useful nutritional value.
Example 2
A composition in accordance with the invention can be prepared according to the following formulation: Inaredient Parts bv Weight
Tissular extract of blood vessels, testicle, prostate, erectile tissue, pituitary gland and neurovascular ) 0.01 system (connective tissue, skin, blood vessels, nerves)
Vitamin mixture (all the B vitamins 50 folic acid, vitamin C and vitamin D)
Flavouring 10
Excipient such as maltodextrin or malt- ) Balance to 100% odextrin and wheat germ (4:1 by weight) ) unit dose weight
The above formulation was prepared in discrete form as 2 gram chewable/suckable tablets.
Example 3
A composition according to Example 2 can be prepared with the addition of the following:
Ingredient Parts by Weight
Ginseng 125
Damiana extract 33
Acerola 75
Example 4
A composition according to Example 2 can be prepared with the addition of the following:
Ingredient Parts bv Weight
Essential and non-essential amino acids 200
Example 5
A composition according to Example 3 can be prepared with the addition of the following:
Ingredient Parts bv Weiqht Essential and non-essential amino acids 200
Zinc Salt 60
Magnesium Salt 25
Calcium Salt 10
Silica Salt 125
Example 6
A composition according to Example 5 can be prepared with the addition of the following::
Ingredient Parts bv Weight
Selenium 0.1
Example 7
A composition according to any one of Examples 2 to 6 can be prepared by replacing the stated tissular extract with a tissular extract of ovary, pituitary, thyroid, blood vessels, liver and neurovascular system.
Example 8
A composition according to any of Examples 2 to 6 can be prepared by replacing the stated tissular extract with a tissular extract of skin, connective tissue, blood vessels and muscle.
Example 9
A composition according to any of Examples 2 to 6 can be prepared by replacing the stated tissular extract with a tissular extract of prostate and blood vessels.
Example 10
A composition according to any of Examples 2 to 6 can be prepared by replacing the stated tissular extract with a tissular extract of main brain, hypothalamus, cerebellum and diencephalon.
ExamPle 11
A composition according to any of Examples 2 to 6 can be prepared by replacing the stated tissular extract with a tissular extract of liver, colon, stomach and small intestine.
Example 12
A composition according to any of Examples 2 to 6 can be prepared by replacing the stated tissular extract with a tissular extract of spleen, thymus, bone marrow, tonsil and sinus.
Example 13
A composition according to any of Examples 2 to 6 can be prepared by replacing the stated tissular extract with a tissular extract of cartilage, connective tissue, blood vessels and muscle.
Example 14
A composition in accordance with the invention, and suitable for encapsulation, was prepared according to the following formulation:
Ingredient Amount per Capsule U.S.%RDA
Vitamin C (Ascorbic Acid) 75 mg 125
Vitamin A (Acetate) 375 iu 37.5
Vitamin D (Cholecalciferol) 10 iu 5
Folic Acid 300 mcg 75
Vitamin B12 (Cyanocobalamin) 5 mcg 85
Zinc (as Amino Acid Chelate) 8 mg 55
Manganese (as Amino Acid Chelate) 2 mg
Selenium (as Methionine) 15 mcg
Calcium (as Carbonate) 90 mg 10
Other Ingredients
Damiana Powder 75 mg
Ribonucleic Acid 25 mg
Soy Protein Isolate 25 mg
Adenosine Triphosphate 2 mg
Example 15
A composition believed to be especially useful in the improvement of mental function, and suitable for encapsulation, was prepared according to the following formulation:: Inqredient Amount per Capsule
Vitamin A 750 mcg
Vitamin B1 5 mg
Vitamin B2 1.6 mg
Vitamin B3 18 mg
Vitamin B5 5 mg
Vitamin B6 2 mg
Vitamin B12 2 mcg
Vitamin C 30 mg
Vitamin D3 2.5 mcg
Vitamin E 20 mg
Folic Acid 300 mcg
Biotin 30 mcg
Amino Acids
Alanine 7.6 mg
Arginine 13.2 mg
Aspartic Acid 20.4 mg
Cysteine 2 mg
Glutamic Acid 33.6 mg
Glycine 7.2 mg
Histidine 4.4 mg
Isoleucine 8.4 mg
Leucine 14.4 mg
Lysine 10.8 mg
Methionine 2.4 mg
Phenylalanine 9.2 mg
Proline 8.8 mg
Serine 9.2 mg
Threonine 6.4 mg
Tyros ine 6.4 mg
Valine 8.8 mg
Other Inqredients Lecithin 75 mg
Bee Pollen 50 mg
Ribonucleic Acid 25 mg
Ginkgo Biloba (as 8::1 extract) 25 mg
Adenosine Triphosphate 2 mg
ExamPle 16
A composition believed to be useful in the enhancement of heart function and circulation, and suitable for encapsulation, was prepared according to the following formulation:
Ingredient Amount per Capsule
Vitamin E 20 mg
Selenium (as Amino Acid Chelate) 50 mcg
Magnesium (as Amino Acid Chelate) 10 mg
Amino Acids
Alanine 7.6 mg
Arginine 13.2 mg
Aspartic Acid 20.4 mg
Cysteine 2 mg
Glutamic Acid 33.6 mg
Glycine 7.2 mg
Histidine 4.4 mg
Isoleucine 8.4 mg
Leucine 14.4 mg
Lysine 10.8 mg
Methionine 2.4 mg
Phenylalanine 9.2 mg
Proline 8.8 mg
Serine 9.2 mg
Threonine 6.4 mg
Tyrosine 6.4 mg
Valine 8.8 mg
Other Ingredients
Bee Pollen 50 mg
L-Carnitine 50 mg
Omega 3 Oil (Fish Oil Powder) 50 mg
Ribonucleic Acid 25 mg
Adenosine Triphosphate 2 mg
Example 17
A composition believed to be useful in the control of prostate problems and suitable for encapsulation was prepared according to the following formulation:
Ingredient Amount per Capsule
Zinc (as Amino Acid Chelate) 20 mg
Magnesium (as Amino Acid Chelate) 10 mg
Calcium (as Carbonate) 50 mg
Other Ingredients
L-Histidine 75 mg
Bee Pollen 50 mg
Ribonucleic Acid 25 mg
Adenosine Triphosphate 2 mg
Parsley 50 mg
Example 18
A composition believed to be useful in the control of stress and suitable for encapsulation was prepared according to be following formulation: :
Ingredient Amount per Capsule
Vitamin A 750 mcg
Vitamin B1 5 mg
Vitamin B2 1.6 mg
Vitamin B3 18 mg
Vitamin B5 5 mg
Vitamin B6 2 mg
Vitamin B12 2 mcg
Vitamin C 30 mg
Vitamin D3 2.5 mcg
Vitamin E 20 mg
Folic Acid 300 mcg
Biotin 30 mcg
Calcium (as Amino Acid Chelate) 9 mg
Magnesium (as Amino Acid Chelate) 2.5 mg
Amino Acids
Alanine 3.8 mg
Arginine 6.6 mg
Aspartic Acid 10.2 mg
Cysteine 1 mg
Glutamic Acid 16.8 mg
Glycine 3.6 mg
Histidine 2.2 mg
Isoleucine 4.2 mg
Leucine 7.2 mg
Lysine 5.4 mg
Methionine 1.2 mg
Phenylalanine 4.6 mg
Proline 4.2 mg
Serine 4.6 mg
Threonine 2.3 mg
Tyrosine 3.2 mg
Valine 4.4 mg
Other Inqredients Choline Bitartrate 50 mg
Lecithin 50 mg
Myo-Inositol 50 mg
Valerian (as 4::1 Extract) 25 mg
Ribonucleic Acid 25 mg
Adenosine Triphosphate 2 mg
Example 19
A composition believed to be useful in maintaining a youthful appearance and temperament, and suitable for encapsulation, was prepared according to the following formulation:
Ingredient Amount Per Capsule
Vitamin A 750 mcg
Vitamin B1 5 mg
Vitamin B2 1.6 mg
Vitamin B3 18 mg
Vitamin B5 5 mg
Vitamin B6 2 mg
Vitamin B12 2 mcg
Vitamin C 30 mg
Vitamin D3 2.5 mcg
Vitamin E 20 mg
Folic Acid 300 mcg
Biotin 30 mcg
Zinc (as Amino Acid Chelate) 15 mg
Selenium (as Amino Acid Chelate) 100 mcg
Calcium Pantothenate 11 mg
Iron (as Amino Acid Chelate) 12 mg
Amino Acids
Alanine 7.6 mg
Arginine 13.2 mg
Aspartic Acid 20.4 mg
Cysteine 2 mg
Glutamic Acid 33.6 mg
Glycine 7.2 mg
Histidine 4.4 mg
Isoleucine 8.4 mg
Leucine 14.4 mg
Lysine 10.8 mg Methionine 2.4 mg
Phenylalanine 9.2 mg
Proline 8.8 mg
Serine 9.2 mg
Threonine 6.4 mg
Tyrosine 6.4 mg
Valine 8.8 mg
Other Ingredients
Ginkgo Biloba (as 8:1 extract) 25 mg
Bee Pollen 50 mg
Malic Acid 25 mg
Citric Acid 25 mg
Ribonucleic Acid 25 mg
Adenosine Triphosphate 2 mg
Example 20
A composition believed to be useful in the control of rheumatism and arthritis, and suitable for encapsulation, was prepared according to the following formulation::
Ingredient Amount per Capsule
Vitamin A 750 mcg
Vitamin B1 5 mg
Vitamin B2 1.6 mg
Vitamin B3 18 mg
Vitamin B5 5 mg
Vitamin B6 2 mg
Vitamin B12 2 mcg
Vitamin C 30 mg
Vitamin D3 2.5 mcg
Vitamin E 20 mg
Folic Acid 300 mcg
Biotin 30 mcg
Zinc (as Amino Acid Chelate) 15 mg
Selenium (as Amino Acid Chelate) 50 mcg
Calcium (as Amino Acid Chelate) 13 mg
Boron (as Amino Acid Chelate) 2 mg
Amino Acids
Alanine 3.8 mg
Arginine 6.6 mg
Aspartic Acid 10.2 mg
Cysteine 1 mg
Glutamic Acid 16.8 mg
Glycine 3.6 mg
Histidine 2.2 mg
Isoleucine 4.2 mg
Leucine 7.2 mg
Lysine 5.4 mg
Methionine 1.1 mg
Phenylalanine 4.6 mg
Proline 4.4 mg
Serine 4.6 mg
Threonine 3.2 mg
Tyrosine 3.2 mg
Valine 4.4 mg
Other Ingredients
Ribonucleic Acid 25 mg
Adenosine Triphosphate 2 mg
Bee Pollen 10 mg
ExamPle 21
A composition believed to be useful in the control of immune system problems, and suitable for encapsulation, was prepared according to the following formulation:
Ingredient Amount Per Capsule
Amino Acids
Alanine 7.6 mg
Arginine 13.2 mg
Aspartic Acid 20.4 mg
Cysteine 2.0 mg
Glutamic Acid 33.6 mg
Glycine 7.2 mg
Histidine 4.4 mg
Isoleucine 8.4 mg
Leucine 14.4 mg
Lysine 10.8 mg
Methionine 2.4 mg
Phenylalanine 9.2 mg
Proline 8.8 mg
Serine 9.2 mg
Threonine 6.4 mg
Tyrosine 6.4 mg
Valine 8.8 mg
Other Ingredients
Bee Pollen 50 mg
Astragalus 50 mg
Kelp 50 mg
Ribonucleic Acid 25 mg
Adenosine Triphosphate 2 mg
Example 22
A composition believed to be useful in the control of menopause problems, and suitable for encapsulation, was prepared according to the following formulation:: Inqredient Amount per Capsule
Vitamin E 20 mg
Magnesium Oxide 50 mg
Selenium (as Amino Acid Chelate) 50 mcg
Boron (as Amino Acid Chelate) 2 mg
Amino Acids
Alanine 7.6 mg
Arginine 13.2 mg
Aspartic Acid 20.4 mg
Cysteine 2.0 mg
Glutamic Acid 33.6 mg
Glycine 7.2 mg
Histidine 4.4 mg
Isoleucine 8.4 mg
Leucine 14.4 mg
Lysine 10.8 mg
Methionine 2.4 mg
Phenylalanine 9.2 mg
Proline 8.8 mg
Serine 9.2 mg
Threonine 6.4 mg
Tyrosine 6.4 mg
Valine 8.8 mg
Other Inqredients Amount
Ribonucleic Acid 25 mg
Adenosine Triphosphate 2 mg
Example 23
A composition in accordance with the invention believed to be useful in the control of digestive problems, and suitable for encapsulation, was prepared according to the following formulation:: Inqredients Amount ner Capsule
Vitamin C (Ascorbic Acid) 30 mg
Vitamin A (Acetate) 375 iu
Vitamin E (Di-alpha) 20 mg
Calcium (as Amino Acid Chelate) 2 mg
Magnesium (as Amino Acid Chelate) 1 mg
Manganese (as Amino Acid Chelate) 1 mg
Zinc (as Amino Acid Chelate) 1 mg
Chromium (as Amino Acid Chelate) 5 mcg
Selenium (as Amino Acid Chelate) 5 mcg
Iron (as Amino Acid Chelate) 1 mg
Amino Acids
Alanine 1.9 mg
Arginine 3.3 mg
Aspartic Acid 5.1 mg
Cysteine 0.5 mg
Glutamic Acid 8.4 mg
Glycine 1.8 mg
Histidine 1.1 mg
Isoleucine 2.1 mg
Leucine 3.6 mg
Lysine 2.7 mg
Methionine 0.6 mg
Phenylalanine 2.3 mg
Proline 2.2 mg
Serine 2.3 mg
Threonine 1.6 mg
Tyrosine 1.6 mg
Valine 2.2 mg lefthand panel
Other Ingredients
Equisetum Arvense 200 mg
Fucus 150 mg
Ribonucleic Acid 25 mg
Adenosine Triphosphate 2 mg
Example 24
A composition in accordance with the invention believed to be useful in the control of digestive problems and suitable for encapsulation, was prepared according to the following formulation: Inqredients Amount per Capsule
Calcium Pantothenate 11 mg
Amino Acids
Isoleucine 90 mg
Leucine 90 mg
Valine 90 mg
Other Ingredients
Fucus (as 5:1 Extract) 250 mg
Parsley (as 4:1 Extract) 200 mg
Bee Pollen 50 mg
Ribonucleic Acid 25 mg
Charcoal 125 mg
Adenosine Triphosphate 2 mg
ExamPle 25
A composition in accordance with the invention believed to be useful in the control of weight problems i.e.
"slimming", and suitable for encapsulation was prepared according to the following formulation:
Ingredient Amount per Capsule U.S.%RDA
Vitamin A 500 mcg 62
Vitamin B1 (Thiamine HC1) 1 mg 71
Vitamin B2 (Riboflavin) 1 mg 62
Vitamin B3 (Nicotinamide) 10 mg 55
Vitamin B5 (as Calcium Pantothenate) 6 mg
Vitamin B6 (Pyridoxine HC1) 2 mg
Vitamin B12 (Cyanocobalamin) 2 mcg 200
Folic Acid 200 mcg 100
Biotin 30 mcg
Vitamin C 20 mg 33
Vitamin D 10 iu 200
Vitamin E (Dl-Alpha) 10 mg 100
Calcium 50 mg 6
Magnesium 25 mg 8
Iron 4 mg 7
Copper 200 mcg
Zinc 1.5 mg 10
Iodine 50 mcg 33
Other Ingredients
Beet Fibre 100 mg
Cellulose Fibre 100 mg
Psyllium Fibre 100 mg
Ribonucleic Acid 25 mg
Adenosine Triphosphate 2 mg
It is to be understood that the invention is not limited to the specific details given above and numerous variations and modifications may be made within the spirit and scope of the claims which follow.
Claims (22)
1. A formulated composition for use as a food or food supplement, which composition comprises a proteinaceous component comprising at least one protein, peptide, polypeptide or amino acid and an essential nutrient component comprising at least one nutrient substance which is a vitamin, mineral or trace element, the proteinaceous component being present in an amount of from about lx10 8 g to about 10g per recommended daily allowance of at least one nutrient substance in the essential nutrient component.
2. A composition according to claim 1, which is discrete portion form.
3. A composition according to claim 2, which is in the form of a tablet, lozenge or capsule.
4. A composition according to claim 3, which is in the form of a chewable, suckable, water-soluble tablet or slowrelease tablet or lozenge.
5. A composition according to claim 1, which is in the form of a gum, a powder or a solution or suspension in a non-toxic liquid.
6. A composition according to any one of the preceding claims, wherein the proteinaceous material comprises at least one tissular extract of glands, organs, blood vessels, muscle or skin.
7. A composition according to claim 6, wherein the proteinaceous material comprises at least one tissular extract obtained by filtration or other purification of non-human animal tissue, both foetal and adult, of any type, except bovine tissue.
8. A composition according to any one of the preceding claims, wherein the proteinaceous material comprises ribonucleic acid (RNA) and/or adenosine triphosphate (ATP).
9. A composition according to claim 8, wherein any RNA is present in an amount of from 10 to 50 mg per RDA and any
ATP is present in an amount of from 1 to 10 mg per RDA.
10. A composition according to any one of the preceding claims, which includes one or more of vitamin A, vitamin B1,
B2, B3, B6, B12, folic acid, pantothenic acid, biotin, choline, inositol, para-aminobenzoic acid, vitamin C, vitamin D or vitamin E.
11. A composition according to claim 10, which contains one or more of the following in the given daily allowance:
Vitamin A - about 0.5 to about 1.0 mg
Vitamin B1 - about 0.5 to about 1.5 mg
Vitamin B2 - about 0.5 to about 1.7 mg
Niacin - about 15.0 to about 19.0 mg
Vitamin B6 - about 1.0 to about 2.2. mg
Pantothenic Acid - about 5.0 to about 7.0 mg
Biotin - about 150.0 to about 200.0 mcg
Folic Acid - about 300.0 to about 400.0 mcg
Vitamin B12 - about 2.0 to about 3.0 mcg
Vitamin C - about 30.0 to about 60.0 mg
Vitamin D3 - about 2.5 to about 10.0 mcg
Vitamin E - about 5.0 to about 20.0 mg
12. A composition according to any one of the preceding claims, which includes one or more of calcium, chromium, iodine, iron, magnesium, potassium, selenium, zinc or boron.
13. A composition according to any one of the preceding claims, which contains one or more of the following in the given daily allowance:
Calcium - about 800 mg
Phosphorous - about 800 mg
Magnesium - about 300 mg, for example, about 300 to
about 400 mg, typically about 350 mg
Iron - about 18 mg
Iodine - about 150 mcg
Fluorine - about 1.5 mg, for example, about 1.5 to
about 4.0 mg
Zinc - about 15.0 mg
Copper - from about 2.0 to about 3.0 mg
Manganese - from about 2.5 to about 5.0 mg, typically
about 4 mg
Selenium - about 50 mcg, for example, about 50 to about
200 mcg, typically about 60 mcg
Chromium - about 50 mcg, for example, about 50 to about
200 mcg, typically about 60 mcg
Boron - about 1 to about 5 mg, preferably about 2
mg.
Molybdenum - about 150 mcg, for example, about 150 to
about 500 mcg.
14. A composition according to any one of the preceding claims, which includes one or more enzymes.
15. A composition according to any one of the preceding claims, which includes one or more amino acids.
16. A composition according to claim 13, wherein the amino acid or acids are essential amino acids and comprise one or more of isoleucine, phenylalanine, leucine, threonine, lysine, tryptophan, methionine and valine.
17. A composition according to claim 13, wherein the amino acid or acids are non-essential amino acids and comprise one or more of alanine, glycine, arginine, proline, aspartic acid, serine, cysteine, tyrosine and glutamic acid.
18. A composition according to any one of the preceding claims, wherein the total content of proteinaceous component is no more than about 200 mg per RDA of at least one nutrient substance in the nutrient component.
19. A composition according to any one of the preceding claims in discrete portion form of about 500 to about 2000mg.
20. A composition according to any one of the preceding claims, which includes extracts of herbs such as Damiana,
Aquisetum Arnense, Ginkgo Biloba, Bee Pollen, Fruit Acids,
Guarana, Kelp, Astragalus, Myo-Inositol, Lecithin,
Valerian, L-Carnitine, evening primrose oil and ginseng root.
21. A composition according to claim 1, substantially as hereinbefore described.
22. A composition for use as a food or food supplement substantially as hereinbefore described with reference to any one of the specific Examples.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9313858A GB2268871A (en) | 1992-07-04 | 1993-07-05 | Composition for use as a food or food supplement |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929214247A GB9214247D0 (en) | 1992-07-04 | 1992-07-04 | Composition for use as a food or food supplement |
| GB9313858A GB2268871A (en) | 1992-07-04 | 1993-07-05 | Composition for use as a food or food supplement |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB9313858D0 GB9313858D0 (en) | 1993-08-18 |
| GB2268871A true GB2268871A (en) | 1994-01-26 |
Family
ID=26301199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB9313858A Withdrawn GB2268871A (en) | 1992-07-04 | 1993-07-05 | Composition for use as a food or food supplement |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2268871A (en) |
Cited By (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0732917A4 (en) * | 1990-08-07 | 1997-02-26 | Anthony J Umbdenstock | Nutritional supplement for optimizing cellular health |
| WO1997025972A1 (en) * | 1996-01-17 | 1997-07-24 | Friedrich Kisters | Preparation for improving hair growth, the skin structure and/or nail regeneration |
| WO1998032464A1 (en) * | 1997-01-28 | 1998-07-30 | Goldshield Pharmaceuticals Limited | Pharmaceutical composition comprising at least tyrosine and an iron compound for treating parkinson's disease or depression |
| WO1999037167A3 (en) * | 1998-01-22 | 1999-09-30 | Abbott Lab | Process of improving the stability of vitamin d in a nutritional product containing hydrolyzed protein and product produced thereby |
| WO2000032202A1 (en) * | 1998-12-02 | 2000-06-08 | Philippe Gorny | Method for obtaining and using a combination of a purine and a nitrogen monoxide donor for preventing or treating sexual dysfunction |
| EP0934060A4 (en) * | 1996-07-30 | 2001-01-03 | Energetics | FOOD ADDITIVES |
| EP1068868A3 (en) * | 1997-07-08 | 2001-01-31 | Rath, Matthias, Dr. med. | Synergistic compositions comprising ascorbate and lysine for states related to extracellular matrix degeneration |
| EP1163904A1 (en) * | 2000-06-16 | 2001-12-19 | Rath, Matthias, Dr. med. | Composition for the prevention of smooth muscle diseases comprising ascorbate, arginine and magnesium |
| EP1195159A1 (en) * | 2000-10-09 | 2002-04-10 | Rath, Matthias, Dr. med. | Therapeutic combination of ascorbate with lysine or arginine for prevention and treatment of cancer |
| FR2816211A1 (en) * | 2000-11-08 | 2002-05-10 | Brif | Dietetic composition used for the relief of dryness of the mucous membranes containing prostaglandin precursors, antioxidants, brewers yeast enriched in minerals and optional softening agents |
| WO2002003974A3 (en) * | 2000-07-07 | 2003-01-23 | Nutricia Nv | Composition comprising folic acid and zinc for improving male fertility |
| GB2380656A (en) * | 2001-09-21 | 2003-04-16 | Brand Partnership Ltd | Vitamin supplement for soups |
| US6686340B2 (en) | 2001-06-19 | 2004-02-03 | Matthias Rath | Composition and method for prevention and treatment of health conditions caused by constriction of smooth muscle cells |
| US6693129B2 (en) * | 2000-10-03 | 2004-02-17 | Matthias Rath | Compositions and methods for lowering plasma lipoprotein(A) and risk factors of cardiovascular diseases |
| WO2004041166A3 (en) * | 2002-10-31 | 2004-07-29 | Balchem Corp | Dosage forms containing stabilized choline and method for preparing same |
| SG106614A1 (en) * | 2001-06-21 | 2004-10-29 | Matthias Rath Dr | Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body |
| US6974833B2 (en) | 2001-01-16 | 2005-12-13 | Matthias Rath | Synergistic compositions comprising ascobate and lysine for states related to extra cellular matrix degeneration |
| WO2006021278A1 (en) | 2004-08-26 | 2006-03-02 | Merz Pharma Gmbh & Co. Kgaa | Compositions containing a capillary active system with application-related differentiability, and the use thereof |
| WO2007031291A3 (en) * | 2005-09-14 | 2007-05-10 | Mark Warnecke | Foodstuff additive |
| EP2224930A4 (en) * | 2008-01-04 | 2011-06-22 | Nestec Sa | COMPOSITIONS COMPRISING UNSATURATED FATTY ACIDS AND NITRIC OXIDE LIBERATING COMPOUNDS AND THEIR USE FOR ENHANCING COGNITIVE AND RELATED FUNCTIONS |
| IT202000006124A1 (en) * | 2020-03-23 | 2021-09-23 | Labomar S P A | Composition to attenuate enteric barrier dysfunction induced by non-steroidal anti-inflammatory drugs |
| WO2023149109A1 (en) * | 2022-02-02 | 2023-08-10 | 株式会社ニチレイフーズ | Acerola dry powder and method for manufacturing same |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4237118A (en) * | 1972-03-06 | 1980-12-02 | Howard Alan N | Dietary supplement and dietary methods employing said supplement for the treatment of obesity |
| US4499076A (en) * | 1982-01-22 | 1985-02-12 | Ajinomoto Company Incorporated | Elemental diets for liver diseases |
| US4973467A (en) * | 1989-10-13 | 1990-11-27 | Natrol, Inc. | Dietary supplement for adults |
| US5002780A (en) * | 1987-07-31 | 1991-03-26 | Caola Kozmetikai Es Haztartasvegyipari Vallalat | Magnesium salt of a fatty acid acyl lactylate |
-
1993
- 1993-07-05 GB GB9313858A patent/GB2268871A/en not_active Withdrawn
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4237118A (en) * | 1972-03-06 | 1980-12-02 | Howard Alan N | Dietary supplement and dietary methods employing said supplement for the treatment of obesity |
| US4499076A (en) * | 1982-01-22 | 1985-02-12 | Ajinomoto Company Incorporated | Elemental diets for liver diseases |
| US5002780A (en) * | 1987-07-31 | 1991-03-26 | Caola Kozmetikai Es Haztartasvegyipari Vallalat | Magnesium salt of a fatty acid acyl lactylate |
| US4973467A (en) * | 1989-10-13 | 1990-11-27 | Natrol, Inc. | Dietary supplement for adults |
Cited By (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0732917A4 (en) * | 1990-08-07 | 1997-02-26 | Anthony J Umbdenstock | Nutritional supplement for optimizing cellular health |
| WO1997025972A1 (en) * | 1996-01-17 | 1997-07-24 | Friedrich Kisters | Preparation for improving hair growth, the skin structure and/or nail regeneration |
| US6331569B1 (en) | 1996-01-17 | 2001-12-18 | Friedrich Kisters | Preparation for improving hair growth, the skin structure and/or nail regeneration |
| EP0934060A4 (en) * | 1996-07-30 | 2001-01-03 | Energetics | FOOD ADDITIVES |
| US6200607B1 (en) * | 1997-01-28 | 2001-03-13 | Keith Bridgeman | Pharmaceutical composition comprising at least tyrosine and an iron compound for treating parkinson's disease or depression |
| WO1998032464A1 (en) * | 1997-01-28 | 1998-07-30 | Goldshield Pharmaceuticals Limited | Pharmaceutical composition comprising at least tyrosine and an iron compound for treating parkinson's disease or depression |
| BE1013921A3 (en) * | 1997-07-08 | 2002-12-03 | Rath Matthias | Composition for treating collagenase-linked degenerative diseases, e.g. atherosclerosis, cancer and infections, comprises ascorbate and a fibrinolysis inhibitor |
| GB2370988A (en) * | 1997-07-08 | 2002-07-17 | Matthias Rath | Synergistic compositions comprising ascorbate and lysine for states related to extra cellular matrix degeneration |
| EP1068868A3 (en) * | 1997-07-08 | 2001-01-31 | Rath, Matthias, Dr. med. | Synergistic compositions comprising ascorbate and lysine for states related to extracellular matrix degeneration |
| FR2819413A1 (en) * | 1997-07-08 | 2002-07-19 | Matthisa Rath | Composition for treating collagenase-linked degenerative diseases, e.g. atherosclerosis, cancer and infections, comprises ascorbate and a fibrinolysis inhibitor |
| WO1999037167A3 (en) * | 1998-01-22 | 1999-09-30 | Abbott Lab | Process of improving the stability of vitamin d in a nutritional product containing hydrolyzed protein and product produced thereby |
| WO2000032202A1 (en) * | 1998-12-02 | 2000-06-08 | Philippe Gorny | Method for obtaining and using a combination of a purine and a nitrogen monoxide donor for preventing or treating sexual dysfunction |
| EP1163904A1 (en) * | 2000-06-16 | 2001-12-19 | Rath, Matthias, Dr. med. | Composition for the prevention of smooth muscle diseases comprising ascorbate, arginine and magnesium |
| WO2002003974A3 (en) * | 2000-07-07 | 2003-01-23 | Nutricia Nv | Composition comprising folic acid and zinc for improving male fertility |
| US7244749B2 (en) | 2000-10-03 | 2007-07-17 | Matthias Rath | Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases |
| US6693129B2 (en) * | 2000-10-03 | 2004-02-17 | Matthias Rath | Compositions and methods for lowering plasma lipoprotein(A) and risk factors of cardiovascular diseases |
| EP1195159A1 (en) * | 2000-10-09 | 2002-04-10 | Rath, Matthias, Dr. med. | Therapeutic combination of ascorbate with lysine or arginine for prevention and treatment of cancer |
| EP1216623A1 (en) * | 2000-11-08 | 2002-06-26 | Brif | Dietary and/or cosmetic compositions for counteracting dryness of mucous membranes |
| FR2816211A1 (en) * | 2000-11-08 | 2002-05-10 | Brif | Dietetic composition used for the relief of dryness of the mucous membranes containing prostaglandin precursors, antioxidants, brewers yeast enriched in minerals and optional softening agents |
| US6974833B2 (en) | 2001-01-16 | 2005-12-13 | Matthias Rath | Synergistic compositions comprising ascobate and lysine for states related to extra cellular matrix degeneration |
| US6686340B2 (en) | 2001-06-19 | 2004-02-03 | Matthias Rath | Composition and method for prevention and treatment of health conditions caused by constriction of smooth muscle cells |
| SG106614A1 (en) * | 2001-06-21 | 2004-10-29 | Matthias Rath Dr | Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body |
| GB2380656A (en) * | 2001-09-21 | 2003-04-16 | Brand Partnership Ltd | Vitamin supplement for soups |
| WO2004041166A3 (en) * | 2002-10-31 | 2004-07-29 | Balchem Corp | Dosage forms containing stabilized choline and method for preparing same |
| EP1781330B1 (en) * | 2004-08-26 | 2013-03-27 | Merz Pharma GmbH & Co. KGaA | Compositions containing a capillary active system with application-related differentiability, and the use thereof |
| WO2006021278A1 (en) | 2004-08-26 | 2006-03-02 | Merz Pharma Gmbh & Co. Kgaa | Compositions containing a capillary active system with application-related differentiability, and the use thereof |
| EP2269649A3 (en) * | 2004-08-26 | 2011-08-10 | Merz Pharma GmbH & Co. KGaA | Compositions containing a capillary active system with application-related differentiability, and the use thereof |
| WO2007031291A3 (en) * | 2005-09-14 | 2007-05-10 | Mark Warnecke | Foodstuff additive |
| AU2008347177B2 (en) * | 2008-01-04 | 2014-04-17 | Société des Produits Nestlé S.A. | Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions |
| EP2224930A4 (en) * | 2008-01-04 | 2011-06-22 | Nestec Sa | COMPOSITIONS COMPRISING UNSATURATED FATTY ACIDS AND NITRIC OXIDE LIBERATING COMPOUNDS AND THEIR USE FOR ENHANCING COGNITIVE AND RELATED FUNCTIONS |
| EP3058942A1 (en) * | 2008-01-04 | 2016-08-24 | Nestec S.A. | Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions |
| US10111911B2 (en) | 2008-01-04 | 2018-10-30 | Nestec S.A. | Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions |
| US10973859B2 (en) | 2008-01-04 | 2021-04-13 | Société des Produits Nestlé S. A. | Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions |
| US11951137B2 (en) | 2008-01-04 | 2024-04-09 | Société des Produits Nestlé S.A. | Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions |
| IT202000006124A1 (en) * | 2020-03-23 | 2021-09-23 | Labomar S P A | Composition to attenuate enteric barrier dysfunction induced by non-steroidal anti-inflammatory drugs |
| WO2023149109A1 (en) * | 2022-02-02 | 2023-08-10 | 株式会社ニチレイフーズ | Acerola dry powder and method for manufacturing same |
| JP7357823B1 (en) * | 2022-02-02 | 2023-10-06 | 株式会社ニチレイフーズ | Acerola dry powder and its manufacturing method |
| EP4473845A4 (en) * | 2022-02-02 | 2025-08-20 | Nichirei Foods Inc | ACEROLA DRY POWDER AND METHOD FOR PRODUCING SAME |
Also Published As
| Publication number | Publication date |
|---|---|
| GB9313858D0 (en) | 1993-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2268871A (en) | Composition for use as a food or food supplement | |
| WO1994001006A2 (en) | Composition for use as a food or food supplement | |
| EP1551239B1 (en) | Drink composition | |
| US7238373B2 (en) | Nutritional supplement | |
| CN108651998A (en) | It is a kind of have relieve fatigue PURE WHEY of function and preparation method thereof | |
| CN108967800A (en) | A kind of functional solid beverage and preparation method thereof | |
| CN108703249A (en) | A kind of collagen product and preparation method thereof | |
| JP2012171901A (en) | Food for oral-intake for hair growth of men | |
| CN106852937A (en) | Promote hair tonic, pre-Anti-hair loss and improve hair follicle with edible cricket composition | |
| CN113598377A (en) | Composition for improving anemia, functional food thereof, preparation method and application | |
| KR100463414B1 (en) | Food-supplement for sports nutrition | |
| KR100509983B1 (en) | Healthy food composition for accelerating growth | |
| KR20160096294A (en) | Crickets for improved liver function, liver cancer, hangover solutions, fatigue recovery and food compositions comprising the same | |
| CN1315418C (en) | Instant drinking powder contg. black-fungus, oatmeal and spirulina, and its prepn. method | |
| CN102579956B (en) | Medicament composition and application thereof | |
| CN106036387A (en) | Super chenopodium quinoa willd nutritional packet for promoting growth of children | |
| CN109845870A (en) | A kind of haematococcus pluvialis vitamin C pressed candy and preparation method thereof | |
| CN103478718A (en) | Functional food for improving glutathione concentration in human body and preparation method thereof | |
| CN108450962A (en) | A kind of solid beverage and preparation method thereof for Woman health | |
| JP2001348334A (en) | Nutrition supplement | |
| KR20100042078A (en) | Dietary food constituents | |
| CN101507488A (en) | Composite reinforced nutritious chicken essence | |
| CN106072252A (en) | Increasing intelligence containing Semen Maydis edible fungi nut encourages nutritional jelly and production method thereof | |
| CN107136490A (en) | A kind of peptide Chinese caterpillar fungus health product | |
| RU2323599C1 (en) | Biologically active food additive and its production method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |